C

    Context Therapeutics Inc (CNTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    +0.01 (+1.56%)

    Market Cap: $35.81M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(10/19)
    Avg Surprise
    -17.65%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.11
    Range$-0.16 - $-0.07
    8 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.10+10.4%
    60d ago$-0.10+10.4%
    30d ago$-0.10+10.4%
    7d ago$-0.10+8.1%
    Current$-0.11
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.14
    Range$-0.25 - $-0.08
    8 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.14---
    Sep 26EST
    		-$-0.11---
    Jun 26
    Reported Aug 5
    		$-0.15$-0.10-50.00%Miss-66.7%
    Mar 26
    Reported May 6
    		$-0.09$-0.12+25.00%Beat-80.0%
    Dec 25
    Reported Mar 25
    		$-0.14$-0.10-36.59%Miss-366.7%
    Sep 25
    Reported Nov 5
    		$-0.10$-0.09-11.11%Miss+54.5%
    Jun 25
    Reported Aug 6
    		$-0.09$-0.05-80.00%Miss-125.0%
    Mar 25
    Reported May 7
    		$-0.05$-0.06+16.67%Beat+78.3%
    Dec 24
    Reported Mar 20
    		$-0.03$-0.06+47.09%Beat+92.9%
    Sep 24
    Reported Nov 6
    		$-0.22$-0.09-144.44%Miss+40.5%
    Jun 24
    Reported Aug 7
    		$-0.04$-0.07+42.86%Beat+87.1%
    Mar 24
    Reported May 8
    		$-0.23$-0.44+47.73%Beat+42.5%
    Dec 23
    Reported Mar 21
    		$-0.42$-0.35-20.00%Miss-90.9%
    Sep 23
    Reported Nov 9
    		$-0.37$-0.31-19.35%Miss-54.2%
    Jun 23
    Reported Aug 9
    		$-0.31$-0.20-55.00%Miss-24.0%
    Mar 23
    Reported May 10
    		$-0.40$-0.19-110.53%Miss-81.8%
    Dec 22
    Reported Mar 22
    		$-0.22$-0.22+0.00%Beat+62.1%
    Sep 22
    Reported Nov 9
    		$-0.24$-0.25+4.00%Beat+47.8%
    Jun 22
    Reported Aug 11
    		$-0.25$-0.25+0.00%Beat-125.8%
    Mar 22
    Reported May 11
    		$-0.22$-0.24+8.33%Beat+75.0%
    Dec 21
    Reported Mar 24
    		$-0.58$-0.58+0.00%Beat-
    Sep 21
    Reported Dec 2
    		$-0.46$0.00N/AMiss-
    Jun 21
    Reported Jul 2
    		$0.97$0.00N/ABeat-
    Sep 18
    Reported Nov 9
    		$-0.88$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.81EV/EBITDA1.60x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-76.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio5.81xQuick Ratio5.81x
    Trading Statistics
    Beta1.75Avg Volume2.33M
    52-Week High$3.6252-Week Low$0.38

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.45
    SMA 20$0.49
    SMA 50$0.56
    SMA 200$1.65
    EMA 10$0.44
    EMA 20$0.49
    EMA 50$0.73
    EMA 200$1.34

    MACD

    Line: -0.07Signal: -0.07Hist: 0.00

    ADX

    ADX: 34.7+DI: 14.9-DI: 38.5

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down100.0
    PSAR$0.51

    Bollinger Bands

    Upper Band$0.63
    Lower Band$0.34
    %B Position5941%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    30.6

    Momentum Oscillators

    Stoch %K7.8
    Stoch %D12.5
    Williams %R-91.2
    ROC (10d)-26.5%
    Momentum-0.14
    CCI (20d)-141.8
    MFI (14d)29.4

    Volatility Measures

    ATR (14d)$0.05(12.7%)
    StdDev (20d)0.07
    Hist Vol127.4%(High)

    Volume Flow

    VWAP$0.39
    OBV-25.4M
    AD Line-54.6M
    CMF (20d)-0.071

    Volume Metrics

    Avg Vol (20d)2.4M
    Vol Ratio0.5x
    VWMA (20d)$0.49

    Pivot Points

    R3$0.45
    R2$0.44
    R1$0.41
    Pivot Point$0.40
    S1$0.37
    S2$0.35
    S3$0.33

    Advanced Oscillators

    TSI-31.86
    Ultimate Osc34.6
    KST-229.84

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$18,952$0
    Cost of Revenue$0$0$32,277$0$0$0$5,136$0$0$0$2,568$0
    Gross Profit$0$0$-32,277$0$0$0N/A$0$0$0$16,384$0
    Operating Expenses$14.97M$9.34M$13.80M$10.61M$9.76M$5.53M$4.31M$18.70M$3.09M$3.82M$6.93M$6.18M
    R&D$12.53M$7.02M$11.84M$8.72M$7.83M$3.46M$2.52M$16.83M$1.38M$1.97M$5.30M$4.49M
    SG&A$2.44M$2.33M$1.96M$1.89M$1.93M$2.07M$1.79M$1.88M$1.70M$1.85M$1.63M$1.70M
    Operating Income$-14,967,491$-9,343,799$-13,804,646$-10,610,480$-9,758,362$-5,529,143$-4,310,422$-18,701,428$-3,088,549$-3,823,501$-6,933,205$-6,180,495
    Interest Income$418,663$520,139$682,484$833,772$903,772$958,517$964,036$1.24M$840,150$152,351$0$0
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$-290,440
    Income Before Tax$-14,558,426$-8,680,572$-13,025,607$-9,693,237$-8,827,510$-4,577,261$-3,342,908$-17,459,893$-2,254,506$-3,667,797$-6,769,886$-5,874,686
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-14,558,426$-8,680,572$-13,025,607$-9,693,237$-8,827,510$-4,577,261$-3,342,908$-17,459,893$-2,254,506$-3,667,797$-6,769,886$-5,874,686
    EBITDA$-14,931,616$-9,164,606$-13,704,026$-10,495,486$-9,700,492$-5,505,711$-4,304,010$-3,934,266$-3,092,088$-3,817,580$-6,992,037$-6,154,515
    EBIT$-14,977,089$-9,200,711$-13,708,091$-10,527,009$-9,731,282$-5,535,778$-4,306,944$-18,703,580$-3,094,656$-3,820,148$-6,994,605$-6,165,126
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CNTX

    News

    Context Therapeutics Inc. Revenue Breakdown – NASDAQ:CNTX

    This article provides a revenue breakdown for Context Therapeutics Inc. (NASDAQ: CNTX) based on data available on TradingView. It indicates that the market was closed with no trades recorded at the time of publication. The page primarily offers navigation to financial data, documents, news, and community sections related to CNTX.

    TradingView•8/21/26•
    Neutral

    Enterprise value to EBITDA forward of Context Therapeutics Inc. – NASDAQ:CNTX

    This article displays the Enterprise Value to EBITDA forward for Context Therapeutics Inc. (NASDAQ: CNTX). It provides basic financial information related to the company within the TradingView platform. The content is primarily a data point display from a financial charting service.

    TradingView•8/19/26•
    Neutral

    A Quick Look at Today's Ratings for Context Therapeutics(CNTX.US), With a Forecast Between $2 to $5

    This article provides an overview of current analyst ratings for Context Therapeutics (CNTX.US), indicating a consensus forecast price between $2 and $5. It highlights recent analyst activities, including new coverage or reiterated ratings, which are crucial for investors following the stock. The information aims to offer a quick insight into the market's professional expectations for the company's stock performance.

    Moomoo•8/17/26•
    Neutral

    MPM BioImpact reports 1.4% stake in Context Therapeutics (CNTX) common stock

    MPM BioImpact LLC has filed an Amendment No. 2 to a Schedule 13G, disclosing a beneficial ownership of 1,299,046 shares of Context Therapeutics Inc. (CNTX) common stock, which represents 1.4% of the outstanding class. The firm holds sole voting and dispositive power over these shares and its stake is now reported to be 5% or less of this class of securities. This filing indicates a neutral impact on the stock.

    Stock Titan•8/14/26•
    Neutral

    Blue Owl Capital Holdings (CNTX) reports 3.19% beneficial stake in Context Therapeutics

    Blue Owl Capital Holdings LP has reported a 3.19% beneficial ownership stake in Context Therapeutics Inc., amounting to 2,934,015 shares. This disclosure, made via an Amendment No. 3 to its Schedule 13G filing, indicates that Blue Owl holds sole voting and dispositive power over these shares, representing less than 5% of the class. The ownership percentage is calculated based on 91,879,177 shares outstanding as of May 4, 2026.

    Stock Titan•8/12/26•
    Neutral

    Frequently Asked Questions About CNTX

    Does CNTX pay dividends?
    Context Therapeutics Inc (CNTX) does not currently pay a regular dividend.
    What is CNTX's market cap?
    Context Therapeutics Inc (CNTX) has a market capitalization of $35.81M with a current stock price of $0.39.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In